Dementia 03564...Australia
An 85-year-old man sought treatment for his short-term memory loss which started two years ago. His main symptom was repeating the same question or dialogue several times, not realizing that he was repeating them. He could remember events of the past and the names of people easily. The Mini Mental State Examination (MMSE)* score taken in March 2017 was 23, suggestive of mild dementia. Since then, he took a herbal supplement regularly though it did not help. He was a very cheerful man and did regular walks twice daily.
He was taking allopathic medication for other ailments such as hypertension, benign prostate hyperplasia (BPH) etc which were under good control but he did not want to take allopathy for memory loss whereas his family was much concerned since his symptoms were slowly becoming worse. On 24 May 2019, he consulted the practitioner who gave:
#1. CC12.1 Adult tonic + CC14.2 Prostate + CC15.1 Mental & Emotional tonic + CC17.3 Brain & Memory tonic + CC18.2 Alzheimer’s disease + CC18.5 Neuralgia…QDS
He stopped the herbal supplement immediately and took the vibro remedy diligently without missing a dose. Over the next several months, his condition did not deteriorate. On 3 Nov, he was also given:
#2. CC17.2 Cleansing…OD
In May 2020, although his MMSE score remained the same, his family was happy for him to continue the treatment as his condition remained stable. #2 was stopped in Sep 2020. By 12 Dec, his dialogue repetition came down noticeably (the progress was not quantifiable) and the dosage was reduced to TDS. He remained independent, active and cheerful. By 28 May 2021, there was further improvement and the dosage was reduced to BD. By Oct 2022 the memory loss became almost negligible and as of Feb 2023, he remains stable. He is happy to continue the remedy at BD.
*The MMSE or Folstein test is a 30-point questionnaire used extensively in clinical and research settings to measure cognitive impairment and to estimate its severity and progression. It helps to follow the course of cognitive changes in an individual over time, thus making it an effective way to document an individual's response to treatment. A score of 24 or more out of 30 indicates a normal cognition.